Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114789) titled 'A multicenter prospective cohort study comparing the efficacy and safety of telitacicept and belimumab in the treatment of systemic lupus erythematosus' on Dec. 17, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shandong Provincial Qianfoshan Hospital
Condition:
Systemic lupus erythematosus
Intervention:
Belimumab group (total systemic lupus erythematosus population):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Belimumab group (total systemic lupus erythematosus population):90;Telitacicept Group(the ove...